External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CHDI 2022

-
Coming soon
02:10 PM
Duration 55mins Palm Springs, California, USA
CHDI 2022: Understanding the treatment and post-treatment effects of tominersen in the Phase III GENERATION HD1 study
Lauren Boak, Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:55 AM
Duration 35mins Palm Springs, California, USA
Digital monitoring of cognitive and motor symptoms in Huntington’s disease: preliminary longitudinal findings from the GENERATION HD1 study of tominersen
Jonas Dorn, Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar